Next-Generation 3D Culture–Derived Conditioned Medium and Extracellular Vesicles for Neuroregeneration

Current advances in regenerative medicine are shifting the focus toward innovative cell-free strategies, with conditioned medium (CM) and extracellular vesicles (EVs) emerging as key mediators of tissue repair and functional recovery following acute spinal cord injury (SCI). Mesenchymal stem cells (MSC) and neural progenitor cells (NPC) secrete bioactive molecules into CM, including critical proteins (VEGF, bFGF, IL-10, BDNF, NGF) and ECVs enriched with proteins, lipids, and RNA, which are instrumental in modulating inflammation and supporting CNS repair. Traditional 2D cultures fail to replicate the natural cellular environment, which can compromise functional stability and limit therapeutic potential. In contrast, advanced 3D culture systems more accurately mimic the cellular microenvironment, promoting functional stability and enhancing the efficient production of therapeutic molecules. Despite these advances, current CM/ECVs products remain suboptimal for addressing the specific and urgent needs of acute SCI. Preconditioning MSC/NPC with inflammatory cytokines or growth factors has shown promise in enhancing the therapeutic efficacy of CM/ECV by stimulating release of more complex bioactive molecules. This project aims to develop advanced CM/ECV derived from 3D culture systems, optimized for rapid application in acute injury scenarios and enriched with neuroprotective, anti-inflammatory, and antioxidant properties. The therapeutic potential of advanced CM/ECV products will be rigorously assessed through in vitro models of inflammation, oxidative stress, and neuroregeneration, as well as pilot in vivo trials in dogs with SCI. These studies will provide robust evidence of the safety and efficacy of CM/ECV as adjunct therapies, offering a multifaceted approach to neuronal regeneration and functional recovery. When combined with physiotherapy and electrostimulation, this comprehensive strategy has the potential to significantly improve outcomes in SCI.